Abstract:
Steroid-resistant nephrotic syndrome (SRNS) is characterized by high range proteinuria and most often focal and segmental glomerulosclerosis (FSGS). Identification of mutations in genes causing SRNS has improved our understanding of disease mechanisms and highlighted defects in the podocyte, a highly specialized glomerular epithelial cell, as major factors in disease pathogenesis. By exome sequencing, we identified missense mutations in TBC1D8B in two families with an Xlinked early-onset SRNS with FSGS. TBC1D8B is an uncharacterized Rab-GTPase activating protein likely involved in endocytic and recycling pathways. Immunofluorescence studies revealed TBC1D8B presence in human glomeruli, and affected individual podocytes displayed architectural changes associated with migration defects commonly found in FSGS. In zebrafish we demonstrated that both knockdown and knockout of the unique TBC1D8B ortholog induced proteinuria and that this phenotype was rescued by human TBC1D8B mRNA injection, but not by any of the 2 mutated mRNAs. We also showed an interaction between TBC1D8B and Rab11b, a key protein in vesicular recycling in cells. Interestingly, both internalization and recycling processes were dramatically decreased in affected individuals' podocytes and fibroblasts confirming the crucial role of TBC1D8B in the cellular recycling processes, probably as a Rab11b GTPase activating protein. Altogether, these results confirmed that pathogenic variations in TBC1D8B are involved in X-linked podocytopathy and points to alterations in recycling processes as a mechanism of SRNS.
TBC1D8B loss-of-function mutations lead to X-linked nephrotic syndrome via defective trafficking pathways Guillaume Dorval 1, 11 in two families with an X-linked early-onset SRNS with FSGS. TBC1D8B is an uncharacterized Rab-GTPase activating protein likely involved in endocytic and recycling pathways.
Immunofluorescence studies revealed TBC1D8B presence in human glomeruli, and affected individual podocytes displayed architectural changes associated with migration defects commonly found in FSGS. In zebrafish we demonstrated that both knockdown and knockout of the unique TBC1D8B ortholog induced proteinuria and that this phenotype was rescued by human TBC1D8B mRNA injection, but not by any of the 2 mutated mRNAs. We also showed an interaction between TBC1D8B and Rab11b, a key protein in vesicular recycling in cells. Interestingly, both internalization and recycling processes were dramatically decreased in affected individuals' podocytes and fibroblasts confirming the crucial role of TBC1D8B in the cellular recycling processes, probably as a Rab11b GTPase activating protein. Altogether, these results confirmed that pathogenic variations in TBC1D8B are involved in X-linked podocytopathy and points to alterations in recycling processes as a mechanism of SRNS.
Main Text
Steroid-resistant nephrotic syndrome (SRNS) is a glomerular disease characterized by massive proteinuria, most often associated with focal and segmental glomerulosclerosis (FSGS) 1 . SRNS is responsible for chronic kidney disease and accounts for 15% of end-stage kidney disease (ESKD) cases in individuals under 25 years of age 2 . In glomeruli, podocytes are terminally differentiated, highly specialized epithelial cells. Podocyte foot processes (FP)
wrap the outer surface of the glomerular capillaries and interdigitate with FP of neighboring podocytes forming specialized cell-cell junctions called slit-diaphragms (SD), a major constituent of the glomerular filtration barrier. Identification of monogenic causes of SRNS involving more than forty genes has helped decipher podocyte physiology 3; 4 . Many studies have reported a strong relationship between the SD and the actin cytoskeleton 4 , and the role of vesicular trafficking has been well established in the maintenance of SD complexes 5; 6 .
Nevertheless, intracellular transport defects have rarely been related to monogenic SRNS 7 .
Now, through studies aiming at identifying new genes mutated in SRNS in two families, we identified a potential actor of endosomal trafficking. The first family (family A) was from Ecuador and presented with isolated congenital SRNS consistent with an X-linked inheritance.
Pedigree and clinical features are described in Figure 1A and Table 1 . Both mutations involved residues conserved from C. elegans to H. sapiens ( Figure S1A-B ).
TBC1D8B is a member of the TBC domain protein family (Tre-2/Bub2/CDC16). Like other TBC proteins, TBC1D8B may function as a Rab-GTPase Activating Protein (Rab-GAP) by binding to specific Rab proteins and stimulating their GTPase activity 8 . Interestingly, in addition to its Rab-GAP (TBC) domain, TBC1D8B contains one GRAM domain repeated two times, which allows binding to lipid rafts, critical elements of SD signaling in podocytes 9 . The two mutations described above are localized within each GRAM domain ( Figure 1F ). TBC1D8B also possesses an EF-Hand domain localized at the C-terminal extremity. A second isoform of TBC1D8B results from alternative splicing events in intron 11, and leads to a shorter 632 amino-acid protein, lacking the C-terminal extremity of the Rab-GAP domain and the entire EF-like domain. However, the catalytic residues (Arg534 and Glu574) are present in both protein isoforms.
The role of TBC1D8B has never been explored either in cell lines or animal models.
Immunofluorescence studies in human kidneys revealed the presence of TBC1D8B both in glomerular podocytes and tubules at early stages (25 weeks) and in mature kidney. In glomeruli, TBC1D8B colocalized with synaptopodin a specific cytosolic protein 10 (Figure 2A ).
To further comprehend the role of TBC1D8B, we undertook functional studies in both zebrafish and human podocytes. Podocytes from individual B (harboring the p.Phe291Ser variant) were conditionally immortalized from the affected individual's nephrectomy specimen using our published methodology 11 . As previously described in some monogenic SRNS, podocytes often display alterations in actin cytoskeleton organization [12] [13] [14] [15] [16] According to the Zebrafish Genome Reference Consortium (GRCz11), tbc1d8b is the only zebrafish ortholog and is located on autosome 5. Only one transcript has been described corresponding to the longer isoform in humans. By whole-mount in situ hybridization in 24 post-fertilization (hpf) zebrafish embryos, we demonstrated tbc1d8b expression in the neural tube, brain, pectoral fins, and the pronephric glomerulus ( Figure S2 ). Functional analyses were then performed in both tbc1d8b knock-down (KD) morphants and knock-out (KO) fish. Morphants were obtained by specifically targeting tbc1d8b with either spliceblocking (MO SPLICE ) or translation-blocking (MO ATG ) morpholino oligonucleotides. The efficacy of MO SPLICE was checked by RT-PCR ( Figure S3A ), and the efficacy of MO ATG was demonstrated by the absence of fluorescence after co-injection of the MO ATG with its tbc1d8b 5'UTR mRNA target fused to the GFP as described in Figure S3B . The tbc1d8b -/mutant fish line was obtained by ENU mutagenesis resulting in a nonsense mutation in exon 9 (European Zebrafish Resource Center -EZRC). The final product is a truncated 468 aminoacid protein missing the Rab-GAP domain (which starts at residue 466). In zebrafish, pericardial edema has been previously reported to be an indirect marker of a glomerular filtration barrier defect and proteinuria 16 , although it is not specific and can be seen in other zebrafish abnormalities (i.e. heart defects, global developmental abnormalities). Such a phenotype was observed in >95% of both MO SPLICE and MO ATG morphants at 96hpf whereas it was found in less than 2% of control MO fish at 96hpf ( Figure 3A-B ). An identical phenotype was obtained in the tbc1d8b -/fish with the expected Mendelian ratio (n=261 -22.9% phenotype in tbcd8b +/offspring) - Figure 3C ).
To characterize the effect of tbc1d8b loss on kidney anatomy, histology was performed and showed a retracted glomerulus in an enlarged Bowman's capsule in tbc1d8b -/fish compared to control ( Figure 3D ). Similar to affected individuals, EM revealed significant FP effacement and disappearance of SD in tbc1d8b -/-KO fish compared to control (number of FP per µm 3.5±0.2 and 5.3±0.2 respectively -p<0.0001) as indicated in Figure 3E and S4.
To confirm the glomerular permeability defect, we set-up a dye-filtration assay. A high molecular-weight FITC-labeled dextran (500kDa) was injected in the cardinal vein of MO SPLICE and MO CONTROL and tbc1d8b -/or tbc1d8b WT zebrafish at 96hpf. We then screened the filtration defects in two different ways. We first measured fluorescence in the retinal vein and showed that fluorescence in the vasculature of MO SPLICE fish was significantly decreased compared to MO CONTROL ( Figure S5 ). We then showed specific glomerular leakage by imaging dye uptake in tubular cells 6 hours-post-injection (6hpi). Fluorescence was observed in tubular cells in KO tbc1d8b -/fish, but not in control fish, revealing a glomerular protein leakage consistent with pericardial edema and EM findings ( Figure 3F ).
To investigate the functional consequences of both mutations, we performed rescue experiments in zebrafish using the human short isoform of WT and mutant mRNAs, since in wild-type human cultured podocytes, the 632 amino-acid short isoform seems to be predominantly expressed ( Figure S6 ). As mentioned previously, edema was described in 97.6% of morphants. However, when mRNA WT (100pg) was co-injected with MO, this ratio fell to 16% (n=148) ( Figure 3G ) with a dose-response effect ( Figure S7 ). Conversely, the mutated mRNA p.Gln246His and mRNA p.Phe291Ser were only able to very partially rescue the phenotype with 80% (n=201) and 68% (n=282) of fish exhibiting pericardial edema respectively ( Figure 3G ). These results indicate that although both mutations are clearly damaging in both individuals, a modest protein residual activity is likely.
As mentioned above, TBC1D8B may act as Rab-GAP, promoting GTP hydrolysis in specific Rab proteins 18 . In mammalian cells including podocytes, Rab-GTPases are mostly involved in vesicular trafficking 19; 20 . To further analyze the role of TBC1D8B in this process, we performed transferrin endocytosis and recycling assays in affected individuals' podocytes and fibroblasts harboring p.Phe291Ser and p.Gln246His variants respectively. Transferrin is a widely used marker for both clathrin-mediated internalization and recycling pathways in most cell types. After internalization from the plasma membrane and before being recycled back to cell surface, transferrin and its receptor accumulate in the perinuclear recycling compartment (PNRC) 21; 22 . We detected a delay in transferrin uptake in affected individuals' cells compared to control. After 15 and 60 min of incubation (in fibroblasts and podocytes respectively most of the fluorescence was found in the PNRC of WT cells. However, endocytosis was significantly slower in mutant fibroblasts and podocytes ( Figure 4A-B and Figure S8A-B ). In addition, analysis of transferrin recycling revealed a significant decrease of normalized fluorescence intensity 45min after transferrin loading in WT podocytes as well as in fibroblasts, whereas it was maintained in the PNRC in affected individuals' cells ( Figure 4C -D and Figure S8C -D). Altogether, these results strongly suggest that both endocytosis and vesicular recycling are altered in affected podocytes.
In cells, PNRC dynamics and recycling are mostly regulated by Rab11. We then hypothesized that TBC1D8B might be a crucial GAP for Rab11 that displays at least two isoforms (Rab11a and Rab11b) 22 both present in mouse podocytes 23 . By coimmunoprecipitation experiments in HEK293T cells, we showed that the Rab-binding domain (RBD) of TBC1D8B was able to interact with a dominant active, GTP-bound, mutant of Rab11b (DA-Rab11b), but not with DA-Rab11a ( Figure 4E-F) . We also observed a specific interaction between endogenous TBC1D8B and DA-Rab11b ( Figure 4G ). In addition, we showed that DA-Rab11b and TBC1D8B Rab-binding domain colocalized at the PNRC when co-expressed in podocytes ( Figure S9 ), but interestingly, the widespread Rab11b signal in WT cells shifted to a very restricted localization to the PNRC in mutant podocytes, which suggests that GTP-bound Rab11b is trapped in the PNRC in cells from affected individual.
( Figure S10A-B) . Altogether, these data strongly suggest that TBC1D8B is a specific Rab11b-GTPase activating protein.
Numerous proteins are subject to Rab11-dependent recycling in various cell types, especially in neurons 24 . However, although it has been shown that some proteins are recycled in a Rab11b-dependent manner 25 , only a few studies explored the role of Rab11b on vesicular trafficking. In 2016, Grimsey et al. reported the crucial role of Rab11b GTP hydrolysis for the initiation of transferrin recycling from the PNRC to the plasma membrane 26 . In podocytes SD integrity is of utmost importance and several SD proteins are subjected to endocytic and recycling events to maintain their regulation 27 . Very recently, mutations in GAPVD1, a Rab5 effector showed to be involved in nephrin regulation at the SD, were reported as disease-causing 28 . In our study, we did not find any interaction between TBC1D8B and Rab5 ( Figure 4F ), suggesting that Rab5 is not a target of TBC1D8B. Thus, our results highly suggest that some podocyte specific proteins could specifically use the Rab11b-dependent recycling pathway, as it has been shown for some SD proteins and the use of the Rab5-dependent pathway 28 . By this means, alterations in Rab11b activation would lead to SD dysregulation, implying that not only endocytosis, but also recycling are of fundamental importance for SD integrity. Indeed, it is likely that mutations in TBC1D8B lead to strong defect in recycling processes in podocytes, that could also induce a defect in transferrin uptake linked to decrease number of receptors at the plasma membrane at steady state.
Altogether, our results confirmed that mutations in TBC1D8B are involved in the development of early SRNS in rare affected individuals. We show herein that vesicular trafficking plays a fundamental role in podocyte disease, especially in SRNS, through a Rab11-dependent recycling process. Recent discoveries in monogenic SRNS and especially in SD regulation during disease through endocytic and recycling pathways would certainly help to develop targeted therapy for affected individuals.
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